Section Arrow
BNGO.NASDAQ
- Bionano Genomics Inc
Quotes are at least 15-min delayed:2025/09/16 21:50 EDT
Regular Hours
Last
 1.78
-0.99 (-35.74%)
Day High 
1.8 
Prev. Close
2.77 
1-M High
5.5 
Volume 
12.29M 
Bid
1.86
Ask
1.87
Day Low
1.5 
Open
1.58 
1-M Low
2.77 
Market Cap 
12.97M 
Currency USD 
P/E 0.02 
%Yield -- 
10-SMA 3.99 
20-SMA 3.87 
50-SMA 3.49 
52-W High 30.516 
52-W Low 1.5 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-43.87/-3.66
Enterprise Value
16.65M
Balance Sheet
Book Value Per Share
9.69
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
30.78M
Operating Revenue Per Share
6.73
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BNGOBionano Genomics Inc1.78-0.99-35.74%0.02PE
HBIOHarvard Bioscience0.4849+0.0454+10.33%-- 
AVTRAvantor12.71+0.32+2.58%12.27PE
BAXBaxter International23.87+0.07+0.29%140.32PE
MBOTMicrobot Medical3.34-0.08-2.34%-- 
Quotes are at least 15-min delayed:2025/09/16 21:50 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, ofwhich the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.